GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 91 filers reported holding GENERATION BIO CO in Q4 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,616,878 | -34.0% | 690,469 | -4.2% | 0.00% | 0.0% |
Q2 2023 | $3,965,248 | +33.7% | 720,954 | +4.6% | 0.00% | 0.0% |
Q1 2023 | $2,965,018 | -5.9% | 689,539 | -14.0% | 0.00% | 0.0% |
Q4 2022 | $3,151,841 | -27.2% | 801,995 | -1.7% | 0.00% | 0.0% |
Q3 2022 | $4,330,000 | +208.8% | 815,576 | +281.8% | 0.00% | – |
Q2 2022 | $1,402,000 | -6.9% | 213,622 | +4.1% | 0.00% | – |
Q1 2022 | $1,506,000 | +199.4% | 205,168 | +189.0% | 0.00% | – |
Q4 2021 | $503,000 | -94.3% | 70,990 | -79.7% | 0.00% | -100.0% |
Q3 2021 | $8,750,000 | -14.1% | 349,034 | -7.8% | 0.00% | 0.0% |
Q2 2021 | $10,185,000 | -31.7% | 378,623 | -27.8% | 0.00% | -50.0% |
Q1 2021 | $14,923,000 | +217.1% | 524,356 | +215.9% | 0.00% | +300.0% |
Q4 2020 | $4,706,000 | +1928.4% | 165,985 | +2107.0% | 0.00% | – |
Q3 2020 | $232,000 | -79.0% | 7,521 | -85.7% | 0.00% | – |
Q2 2020 | $1,105,000 | – | 52,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Life Science Advisors, LLC | 8,278,876 | $43,961,000 | 4.85% |
GREAT POINT PARTNERS LLC | 825,077 | $4,381,000 | 1.06% |
HighVista Strategies LLC | 248,994 | $1,322,000 | 0.76% |
Artal Group S.A. | 2,814,191 | $14,943,000 | 0.64% |
PFM Health Sciences, LP | 3,013,712 | $16,003,000 | 0.58% |
HARVARD MANAGEMENT CO INC | 510,354 | $2,710,000 | 0.34% |
Yiheng Capital Management, L.P. | 997,857 | $5,299,000 | 0.33% |
Bellevue Group AG | 3,627,280 | $19,261,000 | 0.28% |
BVF INC/IL | 361,824 | $1,921,000 | 0.08% |
FARALLON CAPITAL MANAGEMENT LLC | 2,500,000 | $13,275,000 | 0.07% |